Optimum selection criteria for secondary cytoreductive surgery in patients with recurrent epithelial ovarian cancer: A multicenter study from the Gynecologic Oncology Research Investigators coLLaborAtion group (GORILLA-3001).
Sign Up to like & getrecommendations! Published in 2023 at "Journal of surgical oncology"
DOI: 10.1002/jso.27303
Abstract: BACKGROUND To identify those most likely to benefit from secondary cytoreductive surgery (SCS), we evaluated the survival outcomes and factors predictive of prognosis in patients with recurrent ovarian cancer. METHODS We retrospectively reviewed the medical… read more here.
Keywords: oncology; surgery; ovarian cancer; patients recurrent ... See more keywords
Prospective evidence discourages secondary cytoreductive surgery
Sign Up to like & getrecommendations! Published in 2019 at "Nature Reviews Clinical Oncology"
DOI: 10.1038/s41571-019-0309-y
Abstract: (2019) For decades, patients with recurrent ovarian cancer have undergone secondary cytoreductive surgery (SCS). “The prevailing opinion, based on retrospective series and included in the National Comprehensive Cancer Network guidelines, was that surgery should be… read more here.
Keywords: chemotherapy; secondary cytoreductive; surgery; durations months ... See more keywords
Multidisciplinary procedures in the laparoscopic secondary cytoreductive surgery of advanced ovarian cancer
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Gynecological Cancer"
DOI: 10.1136/ijgc-2022-003786
Abstract: Recurrent ovarian cancer is usually associated with complex pelvic conditions. The variable location of metastatic tumors and intestinal adhesions make secondary cytoreductive surgery difficult. In order to provide appropriate surgery, gynecologic oncologists working in medical… read more here.
Keywords: surgery; secondary cytoreductive; ovarian cancer; cytoreductive surgery ... See more keywords
Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer
Sign Up to like & getrecommendations! Published in 2023 at "International Journal of Gynecological Cancer"
DOI: 10.1136/ijgc-2022-003904
Abstract: Objective Retrospective series have shown minimally invasive secondary cytoreductive surgery is a feasible approach in selected cases of recurrent ovarian cancer. However, no predictors of minimally invasive secondary cytoreductive surgery feasibility are currently available. This… read more here.
Keywords: surgery; minimally invasive; secondary cytoreductive; invasive secondary ... See more keywords
Secondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer: A Meta-Analysis
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.21.02085
Abstract: PURPOSE The survival impact of secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer was studied. METHODS We identified published studies from 1983 to 2021 following our inclusion criteria from MEDLINE, EMBASE, and Cochrane… read more here.
Keywords: sensitive recurrent; recurrent ovarian; platinum sensitive; analysis ... See more keywords
Comments on: Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Gynecologic Oncology"
DOI: 10.3802/jgo.2019.30.e111
Abstract: https://ejgo.org The article by Petrillo and colleagues [1] recently presents the cisplatin (CDDP) pharmacokinetic profile in a prospective series of patients enrolled in the HORSE (NCT01539785) trial, a randomized controlled trial exploring the prognostic role… read more here.
Keywords: secondary cytoreductive; hipec women; cytoreductive surgery; women platinum ... See more keywords